Domainex

Activities: Research & Development

Trending Articles

  1. Counteracting counterfeits in the pharmaceutical supply chain Sreedhar Patnala, General Manager at Systech, discusses the comprehensive benefits of embracing traceability
  2. Catalent Boston adds to oral spray drying capacity to support late-stage clinical trials and commercialisation Catalent, the leading provider of oral drug development solutions, bioavailability enhancing technologies and flexible manufacturing, has completed a series of upgrades to its...
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Merck jumps on the GLP-1 therapeutic bandwagon by licensing Hansoh Pharma's HS-10535 Merck will be responsible for the development, manufacture and commercialisation of the investigational preclinical oral GLP-1 receptor agonist
  4. Newcells Biotech raises additional funding from investors Newcells Biotech, a leading drug discovery partner specialising in the development of in vitro models and bespoke assay services to improve the prediction of in vivo human...
  5. You need to be a subscriber to read this article.
    Click here to find out more.
    Industrial data mastery: navigating the 2025 landscape As industrial manufacturers contend with the ever-increasing volume and variety of operational data, the year ahead promises both complexity and opportunity

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

Related Content

Research & Development

Adenosine A2a receptor: novel biophysical fragment screening using polymer-encapsulated nanodiscs

Fragment screening is a useful method for hit identification as it offers an efficient and flexible way to identify novel therapeutic starting points that other techniques may have missed because of the small molecular size of the fragments
Design & Build

New biology centre opened by HM Lord-Lieutenant of Cambridgeshire

The new three-storey facility provides over 24,000 sqft for Domainex’s expanding biology/bioanalytical departments
Drug Delivery

Amphista Therapeutics partners with Domainex drug discovery portfolio

Domainex has experience in the field of TPD with expertise in designing, synthesising, and profiling targeted heterobifunctional protein degraders
Finance

Domainex acquires more than £1m of Waters equipment

The SQ detectors will enable Domainex to increase its capacity to analyse and purify compounds with higher molecular masses
Research & Development

Domainex opens dedicated facility at Unity Campus

“The investment into our new facility has allowed us to create a fully dedicated suite of labs to conduct our biology services”
Drug Delivery

Parkinson’s UK and Domainex collaborate on inflammation therapy

The organisations plan to develop therapies targeting neuroinflammation to slow the progression of Parkinson’s
Research & Development

Queen’s University Belfast enters FLIP inhibitor collaboration

The university will work with Ipsen on the inhibitors, which have been supported by Domainex
Subscribe now